The Forbes Billionaire List 2025 is out, and Elon Musk tops the ranking with his net worth of $342 billion. Among the top 10 ...
Pharmaceutical stocks took a sharp hit today after U.S. President Donald Trump issued a fresh warning about potential tariffs on the sector.
Though the pharma industry is not brought under the ambit of Trump tariffs, they could face a sectoral duty like the ...
Big pharmaceutical stocks mostly rose after President Trump’s executive order exempted medicines from new tariffs. Merck, ...
The United States is amid a dangerous drug shortage. It’s a crisis that endangers patients, undermines our health care system ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Explore more
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
Analysts said tariffs would send prescription drug prices higher. Generic drugs and ingredients that are largely made ...
Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...
With Kennedy now leading the Department of Health and Human Services during a measles outbreak and providing medical advice ...
Medical marketers, ad agencies, physicians and pharma executives gathered for MM+M’s annual Transform conference, held at One ...